EP3616675A1 - Réservoir de stockage pour une station de stockage et de distribution pour médicament - Google Patents

Réservoir de stockage pour une station de stockage et de distribution pour médicament Download PDF

Info

Publication number
EP3616675A1
EP3616675A1 EP18191874.9A EP18191874A EP3616675A1 EP 3616675 A1 EP3616675 A1 EP 3616675A1 EP 18191874 A EP18191874 A EP 18191874A EP 3616675 A1 EP3616675 A1 EP 3616675A1
Authority
EP
European Patent Office
Prior art keywords
section
wall
projections
separating device
storage container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP18191874.9A
Other languages
German (de)
English (en)
Other versions
EP3616675B1 (fr
Inventor
Dietmar Gross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson Rowa Germany GmbH
Original Assignee
Becton Dickinson Rowa Germany GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Rowa Germany GmbH filed Critical Becton Dickinson Rowa Germany GmbH
Priority to EP18191874.9A priority Critical patent/EP3616675B1/fr
Priority to PCT/EP2019/063515 priority patent/WO2020043334A1/fr
Priority to CN201980056289.XA priority patent/CN112638346B/zh
Priority to JP2021510868A priority patent/JP7304938B2/ja
Priority to KR1020217005501A priority patent/KR20210049105A/ko
Publication of EP3616675A1 publication Critical patent/EP3616675A1/fr
Application granted granted Critical
Publication of EP3616675B1 publication Critical patent/EP3616675B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B39/00—Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
    • B65B39/007—Guides or funnels for introducing articles into containers or wrappers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B5/00—Packaging individual articles in containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, jars
    • B65B5/10—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles
    • B65B5/101—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity
    • B65B5/103—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity for packaging pills or tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
    • B65B9/02—Enclosing successive articles, or quantities of material between opposed webs
    • B65B9/04—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material
    • B65B9/045—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material for single articles, e.g. tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F11/00—Coin-freed apparatus for dispensing, or the like, discrete articles
    • G07F11/005—Special arrangements for insuring that only one single article may be dispensed at a time
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F11/00—Coin-freed apparatus for dispensing, or the like, discrete articles
    • G07F11/02—Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines
    • G07F11/44—Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines in which magazines the articles are stored in bulk
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
    • G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles

Definitions

  • the present invention relates to a storage container for a supply and dispensing station for pharmaceuticals.
  • Modern blister machines such as those in the WO 2013/034504 A1 are disclosed, depending on the stage of expansion, several hundred supply and delivery stations for medicines. A plurality of medicament portions of a certain type of medicament are stored in each of these, and one or more medicament portions can be delivered on request. With the blister machines, the medicinal products stored in the supply and delivery stations are put together and blistered individually for the patient according to the medically prescribed times of intake.
  • Corresponding supply and dispensing stations for dispensing one or more individual medicament portions are controlled to compile the medicament portions.
  • a supply and delivery station is controlled, a single medicament portion is separated with a separating device and transferred to a guide device of the blister machine via a delivery opening.
  • a dispensed medication portion possibly with the interposition of a collecting device, is fed to a packaging device, which blisters individual or several medicament portions in accordance with the medical requirements.
  • the separating device used for separating medicament portions is usually designed in the shape of a circular cylinder and is formed in a corresponding guide space of the storage container.
  • a plurality of drug channels are provided on the periphery of the separating device, via which drug portions of the dispensing opening in a bottom surface of the Storage container are fed.
  • Protrusions are formed between the individual drug channels, which are formed in one piece with a main body of the separating device or can be detachably attached to it.
  • the projections regularly have an arcuate circumferential surface which bears against an inner wall of the guide space in which the separating device is arranged (in the context of this application, the term “concern” does not mean that a Full area touches another, but that a small (ring) gap may be formed at least in sections). If one places a surrounding end around the outer lateral surfaces of the projections, a circle results, the radius of which is only slightly smaller than the radius of the receiving space. In the prior art (when the drug channels are neglected), the separating devices therefore have a circular base area.
  • a large number of medicament portions are arranged in the storage containers for the storage and delivery stations.
  • the separating device is rotated through a certain angle in order to feed a medicament portion arranged in a medicament channel to the delivery opening.
  • the separating device rub against each other as well as against the components of the storage container during the separation. This leads to flaking of the drug portions and a kind of drug dust forms. This settles on all components of the storage container, including the wall of the guide section in which the separating device is arranged.
  • the object is achieved according to the invention by a storage container according to claim 1.
  • the storage container according to the invention for a storage and dispensing station for pharmaceutical portions comprises a housing enclosing a receiving space for pharmaceutical portions with a guide section and a bottom surface, an inner wall of the guide section defining a circular cylindrical guide space and wherein the bottom surface has a discharge opening.
  • a separating device with a central axis of rotation is arranged in the guide section of the housing.
  • the separating device comprises a central main section and a plurality of protrusions, each protrusion having two end sections and a central section and wherein a medicament channel is formed in each case between two end sections of adjacent projections.
  • the projections can be flatter than the main body of the guide device, which supports the supply of the drug portions to the drug channels.
  • the outer lateral surface is regularly formed in a circular arc (based on a central axis of rotation) and the projections therefore form (if the drug channels are neglected) a type of hollow cylinder, the outer lateral surface of which rests on the inner wall of the guide section.
  • the projections are designed differently. It is provided according to the invention that the central sections of the projections are recessed with respect to at least one of the end sections and the at least one end section of each projection is designed in such a way that its outer surface rests on the wall of the guide section (in the context of this application the term " It is not expressed that a surface completely touches another, but that a narrow or small (ring) gap that enables rotation of the separating device is formed at least in sections, if necessary.
  • the projections rest against the wall only with a small section (or are slightly spaced apart from it) and, if appropriate, are guided from or on the wall, it being provided according to the invention that it this section is an end section to which a drug channel connects.
  • this section is an end section to which a drug channel connects.
  • the central sections of the projections are "withdrawn” with respect to the end sections, that is, viewed radially, do not extend as far to the wall as at least one of the end sections of each projection.
  • a (wider) gap is therefore provided between the wall and the middle section compared to the aforementioned end sections.
  • the term “gap” in the middle sections merely means that the distance wall / lateral surface of the central section is greater than the distance wall / lateral surface of the end section. If the middle sections are arcuate, this means that the gap between the wall and the central section is designed like a segment of a hollow cylinder. Alternatively, the middle section can also be designed like a kind of secant with respect to the wall, as a result of which the gap would then have the shape of a circular segment.
  • a corresponding design of the protrusions has the result that pharmaceutical dust which arises during the separation can trickle down through the gap in the area of the central sections and is thus quickly led to the floor surface, where it can be guided to a receiving opening in the floor surface if the floor surface is designed accordingly.
  • the configuration of the projections according to the invention results in a reduced friction surface wall / separating device, the force to be used to rotate the separating device is lower. It is essential here that the force required to rotate the separating device in the guide section changes only slightly, even with increased drug dust formation, since less drug dust adheres to the wall. Since the force to be rotated changes only slightly when dust is formed, the separating device can be controlled or rotated more precisely. The likelihood of incorrect dispensing (for example due to poor alignment of a medicament channel at the dispensing opening) is reduced in the storage container according to the invention.
  • the design of the projections according to the invention has a further considerable advantage. Although it is also unavoidable according to the invention that drug dust falls down in the area of the drug channels, the proportion of drug dust falling down in the channels is reduced in relation to the total amount of drug dust, so that less drug dust goes to (and through) the discharge opening in the Floor area. According to the invention, the entry of drug dust in the blister machines is thus avoided, which extends the time intervals between drug-dust-related cleaning and thus reduces the downtime of the blister machine.
  • end sections are uniformly distributed in all the projections. If only one such end section is provided per projection, this means that these end sections (viewed from the axis of rotation) are always arranged on the right or left of the projection. Depending on the direction of rotation, the end sections lying against the wall (hereinafter briefly “projecting” end sections; “projecting” with respect to the central section) are then arranged “at the rear” or “at the front” on the projection.
  • both end sections of a projection are designed such that they abut the wall of the guide section.
  • Appropriate training improves the delivery of a drug portion into the drug channel. The cleaning described above is then no longer possible, but a low-friction rotation of the separating device and a reduction in the entry of drug dust into the drug channels are still guaranteed.
  • the end sections of the projections resting on the wall of the guide section regardless of whether one or both projections are designed accordingly, are distributed symmetrically over the separating device. If three drug channels and thus three projections are provided, this means that the drug channels are each offset by a central angle of 120 ° with respect to the axis of rotation.
  • the projections have a non-stick coating at least in the area of the central section on a lateral surface facing the wall.
  • the separating device has a conical surface with a plurality of recesses aligned with the drug channels.
  • the main section has recesses above the drug channels.
  • Figures 1a and 1b show two oblique views of a preferred first embodiment of the storage container 1 for a supply and dispensing station for pharmaceuticals.
  • the storage container 1 according to the invention is part of the aforementioned storage and delivery station, the storage container usually being detachably arranged on a delivery station (not shown).
  • a delivery station not shown.
  • components can be arranged in the storage container or the delivery station.
  • Figure 1b can be seen, which shows the storage container from below, in the embodiment shown it does not comprise a motor, but only a coupling piece 31, via which a separating device (shown in more detail in the following figures) can be coupled to a motor in the delivery station.
  • the storage container 1 comprises a housing 10 with a circular cylindrical section 11, to which a bottom section 12 is connected at the bottom.
  • the bottom section 12 is connected to the upper part of the housing via a handle 13 with which the storage container 1 can be removed from a corresponding delivery station.
  • a circular recess 22 is arranged around the coupling piece 31, which is described in more detail in the following figures.
  • FIGS. 2a and 2b show top views according to the first embodiment, wherein in both figures a cover 4 is omitted to illustrate the interior of the storage container.
  • a separating device 40 is arranged in a receiving space defined by the circular cylindrical section 11 of the housing. This comprises a central main section 48 and a plurality of projections 42 arranged on the main section 48. These can be formed in one piece with the main section, but it is also possible that these are as releasable components can be fastened to the main section 48.
  • a drug channel 41 is formed between each of two projections 42, via which drug portions arranged in the storage container Figure 2a shown) delivery channel 21 can be fed.
  • the main section 48 of the separating device 40 comprises a conical surface 43 with four depressions 44, which are formed radially on the channels 41 and are intended to support the supply of drug portions to the drug channels.
  • the projections are not designed as sections of a circular hollow cylinder, but are withdrawn or flattened in the central section (with respect to the axis of rotation), i.e. in these areas there is a gap between the projections and the inner wall of the circular cylindrical section 11 of the housing (the exact configuration of the projections in relation to the circular cylindrical section is described in more detail below).
  • the plan view shown has also been omitted and the bottom surface 20 with a delivery opening 21 and a circular recess 22 can be seen.
  • drug portions arranged in the drug channels 41 are delivered when a delivery channel is aligned with the delivery opening.
  • the circular depression 22 is provided for receiving medicinal product dust that is produced when individualizing medicament portions.
  • a coupling device 30 is arranged, via which the separating device can be coupled to a drive, which in the embodiment shown is not arranged in the storage container.
  • the coupling device itself can be made in one piece with the separating device, but usually the separating device and the coupling device are detachably connected to one another, to enable the rapid replacement of the separating device without a coupling device.
  • Figures 3a and 3b show an oblique view and a side view of a section through the first embodiment of the storage container according to the invention, whereby, as in particular Figure 3a it can be seen that the cut is carried out in such a way that it cuts through the separating device 40 between the drug channels 41.
  • a gap is provided between an inner wall 3 of the circular cylindrical section 11 of the housing 10 and an outer circumferential surface 461 of a central section 46 of a projection 42, through which drug dust can trickle down onto the bottom surface 20 (the exact structure of the projections is given with reference described in the following figures).
  • a slot is made in the area of the bottom opening 21 in the circular cylindrical section, through which a retaining section 51 of a retaining means 50 is inserted.
  • the retention section prevents drug portions arranged above the drug channel when a drug channel is aligned at the delivery opening; only the drug portion contained in the channel when aligned is indicated.
  • Figures 4a and 4b also show two sectional views, the section being orthogonal to that of FIGS Figures 3a and 3b is led. Also based on the Figures 4a and 4b it can be seen that a gap is formed between the inner wall 3 of the circular-cylindrical section 11 and a lateral surface 461 of the central section of a projection. Like it Figures 3a and 3b 4a and 4b can also be seen, the bottom surface 20 is designed to slope down towards the center and comprises a depression 22, so that drug dust trickling down the gap can get into the depression 22 via the falling bottom surface. Furthermore, the Figures 4a and 4b It can be seen that the lower surface 49 of the separating device is also formed obliquely, so that a gap is formed between the bottom surface 20 and the separating device, through which drug dust can reach the recess 22.
  • the separating device comprises four channels 41, which are defined by four projections 42.
  • the main body 48 extends beyond the projections 42, ie a circumferential recess is formed in the region of the projections, which supports the supply of the drug portions into the channels 41.
  • the separating device 40 comprises a conical upper surface 43 with four recesses 44 which are aligned with the drug channels. Recesses 44a are formed in the main body 48 and are aligned with the depressions 44 and the drug channels 41 Wells 44 support the delivery of drug portions into the drug channels 41.
  • the projections 42 each comprise two end sections 45 with lateral surfaces 451 and central sections 46 with lateral surfaces 461.
  • the projections are not designed in the form of a circular arc with respect to the central axis of rotation, but that the central sections are withdrawn in this regard, ie the radius in the central sections is smaller than the radius in the end sections. This is explained in more detail with reference to the following figures.
  • Figures 6a and 6b show the arrangement of the separating device 40 in the circular cylindrical guide space provided by the guide section 11 with the inner wall 3.
  • the separating device comprises four channels 41 and four projections 42.
  • the projections lie in the region of the end sections 45 with jacket surfaces 451 on the wall of the guide section 11, whereas a jacket surface 461 of a central section 46 of a projection does not abut the wall, but rather a gap is formed between the jacket surface and the wall. Via this gap, the drug dust produced during the separation can pass the separation device and onto the bottom surface of the storage container.
  • the radius RMA that is to say the distance from the lateral surface to the central axis of rotation DA
  • the middle sections 46 is greater than the radius RMI at the middle sections 46.
  • Figure 8 shows a plan view of a second embodiment of a separating device, which is essentially designed in accordance with the first embodiment, with the exception that only three drug channels 41 are provided. The remaining versions correspond to the first embodiment.
  • Figure 9 shows a third embodiment of the separating device, wherein also in this embodiment both end sections of a projection protrude from the central section, ie the radius RMA at the end sections 45 is greater than the radius RMI at the central sections 46.
  • the central section is based on the central axis of rotation formed in a circular arc and rises gently in the transition area to the end sections.
  • the middle section can also be formed by not being arch-shaped, but simply by forming a straight line between the end sections, which would lead to a gap with a different shape.
  • Figure 10 shows a fourth embodiment of the separating device.
  • this embodiment only one of the end sections of a projection protrudes with respect to the central section, ie only in one of the end sections is the radius RMA greater than the radius RMI of the central section.
  • the “other” end section 47 is configured in exactly the same way as the central section, ie the lateral surface 471 is formed in the region corresponding to the lateral surface 461 of the central section.
  • the separating device When separating drug portions, the separating device is rotated clockwise regularly in accordance with the embodiment shown, ie the projecting end sections run "in front" of a drug channel to the dispensing opening (that in the embodiment shown below the right drug channel is arranged). When rotating counterclockwise, the projecting end portions 45 run after the drug channels.
  • the edges of the projecting end sections 45 formed in the illustrated embodiment are suitable at the transition from the end section / drug channel to detach drug dust adhering to the wall therefrom.
  • the design of the projections according to the invention also ensures in all four embodiments that the friction between the separating device and the wall is reduced due to the reduced contact surface wall / lateral surface compared to storage containers according to the prior art.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Basic Packing Technique (AREA)
EP18191874.9A 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament Active EP3616675B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP18191874.9A EP3616675B1 (fr) 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament
PCT/EP2019/063515 WO2020043334A1 (fr) 2018-08-31 2019-05-24 Réservoir pour une station de réserve et de distribution pour médicaments
CN201980056289.XA CN112638346B (zh) 2018-08-31 2019-05-24 用于药品份的储存及分配站的储存容器
JP2021510868A JP7304938B2 (ja) 2018-08-31 2019-05-24 製薬の貯蔵及び分配ステーション用貯蔵容器
KR1020217005501A KR20210049105A (ko) 2018-08-31 2019-05-24 약품용 보관 및 분배 스테이션을 위한 보관 용기

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18191874.9A EP3616675B1 (fr) 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament

Publications (2)

Publication Number Publication Date
EP3616675A1 true EP3616675A1 (fr) 2020-03-04
EP3616675B1 EP3616675B1 (fr) 2021-04-14

Family

ID=63452479

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18191874.9A Active EP3616675B1 (fr) 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament

Country Status (5)

Country Link
EP (1) EP3616675B1 (fr)
JP (1) JP7304938B2 (fr)
KR (1) KR20210049105A (fr)
CN (1) CN112638346B (fr)
WO (1) WO2020043334A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2227167A (en) * 1939-07-14 1940-12-31 Morton Salt Co Dispenser for tablets
WO2013034504A1 (fr) 2011-09-09 2013-03-14 Carefusion Switzerland 317 Sàrl Système et procédé de conditionnement de doses d'unités de médicament solide
EP2572995A1 (fr) * 2010-05-17 2013-03-27 Yuyama Mfg. Co., Ltd. Cassette de comprimés

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW557277B (en) * 2001-09-30 2003-10-11 Yuyama Mfg Co Ltd Medicine packing apparatus
WO2003091957A1 (fr) * 2002-04-25 2003-11-06 Shoichi Ishida Distributeur automatique d'article du commerce encapsule
GB0315509D0 (en) * 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
DE102006027521B4 (de) * 2006-06-10 2016-01-07 Edwin Kohl Anlage zur personenbezogenen Bestückung von Medikamentenspendern
JP4786002B1 (ja) * 2010-03-01 2011-10-05 株式会社湯山製作所 薬剤払出機の粉除去装置
KR101449717B1 (ko) * 2013-01-02 2014-10-15 주식회사 인포피아 약제 포장장치용 정제 카트리지
AU2013402591A1 (en) 2013-10-09 2016-05-12 Takazono Technology Incorporated Medicine filling device
GB2531996B (en) * 2014-10-20 2018-01-17 Trig1 Ltd Dispensing container with contents level indication
TWI724134B (zh) 2016-03-25 2021-04-11 日商湯山製作所有限公司 片劑盒用轉子以及片劑盒
US10380824B2 (en) * 2017-02-03 2019-08-13 Becton Dickinson Rowa Germany Gmbh Storage and dispensing station for blister packaging machine
EP4044136A1 (fr) * 2017-02-03 2022-08-17 Becton Dickinson Rowa Germany GmbH Station du stockage et distribution pour machine á blisters

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2227167A (en) * 1939-07-14 1940-12-31 Morton Salt Co Dispenser for tablets
EP2572995A1 (fr) * 2010-05-17 2013-03-27 Yuyama Mfg. Co., Ltd. Cassette de comprimés
WO2013034504A1 (fr) 2011-09-09 2013-03-14 Carefusion Switzerland 317 Sàrl Système et procédé de conditionnement de doses d'unités de médicament solide

Also Published As

Publication number Publication date
EP3616675B1 (fr) 2021-04-14
WO2020043334A1 (fr) 2020-03-05
CN112638346B (zh) 2024-05-28
KR20210049105A (ko) 2021-05-04
JP7304938B2 (ja) 2023-07-07
JP2022500103A (ja) 2022-01-04
CN112638346A (zh) 2021-04-09

Similar Documents

Publication Publication Date Title
DE69732559T2 (de) Maschine zur Herstellung von Schwächungslinien an Blisterpackungen
EP2962956B1 (fr) Réservoir pour un dispositif destiné à la distribution automatique de portions individuelles de médicaments
CH672600A5 (fr)
WO2021254739A1 (fr) Récipient de stockage pour une station de stockage et de distribution
EP3389022A1 (fr) Réservoir pour une station de distribution et de stockage
EP3421381B1 (fr) Dispositif de centrage
WO2018141497A1 (fr) Station de stockage et de distribution pour un automate d'emballages thermoformés
EP3616675B1 (fr) Réservoir de stockage pour une station de stockage et de distribution pour médicament
WO2016113291A1 (fr) Dispositif d'emballage de médicaments
EP3463731B1 (fr) Plaquette de coupe pour un outil de fraisage et outil de fraisage
EP2242469B1 (fr) Dispositif d'emballage du type blister
EP3340763B1 (fr) Dispositif de dosage de matière granulaire avec une unité de pré-dosage
WO2003037760A1 (fr) Dispositif de separation de bouteilles de boisson presentant une collerette
DE2651723B2 (de) Vorrichtung zum Verteilen eines Auskleidungsmaterials in Blechkörper
EP1682070A1 (fr) Machine pour remplir et fermer des capsules en deux parties
EP3407854A1 (fr) Réservoir destiné à une station de stockage et de délivrance de médicaments
WO2021254738A1 (fr) Contenant de stockage destiné à une station de stockage et de distribution
EP3926594A1 (fr) Récipient de stockage pour une station de distribution et de stockage
DE10132180A1 (de) Vorrichtung zum Ausrichten von zweiteiligen Kapseln
DE102018111809A1 (de) Vorrichtung zum entfernen von abfällen aus bogenförmigem material, maschine und zugehöriges verfahren
WO2018206571A1 (fr) Dispositif de fabrication d'un produit d'emballage tridimensionnel, tel qu'un produit rembourré, à partir d'une bande de papier monocouche ou multicouche
DE3539345A1 (de) Vorrichtung zum aufgurten von staebchenfoermigen bauelementen, insbesondere elektrischen bauelementen (melfs)
EP3879503A1 (fr) Station de stockage et de distribution de médicaments
EP4067245A1 (fr) Station de stockage et de distribution pour un distributeur automatique de blister
WO2022089973A1 (fr) Récipient de stockage pour une station de stockage et de distribution, et station de stockage et de distribution

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200626

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210114

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502018004781

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1381646

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210515

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210714

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210714

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210816

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210814

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210715

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502018004781

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20220117

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210814

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20180831

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20230721

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230720

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230720

Year of fee payment: 6

Ref country code: DE

Payment date: 20230720

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414